[Loss of heterozygosity induced by cyclophosphamide at tk locus in human lymphoblastoid cell line TK6]. 2005

Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
National Chengdu Center for Safety Evaluation of Traditional Chinese Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.

OBJECTIVE Human lymphoblastoid cell line TK6 was used to investigate TK gene mutation frequency and the loss of heterozygosity (LOH) induced by cyclophosphamide (CP). METHODS Relative survival, mutation frequency at tk locus induced by CP (+S9) after 4 h treatment were detected. DNA isolated from mutants in the control culture and CP treatment group was analyzed for LOH. RESULTS Exposure to CP for 4 h decreased relative survival, induced TK gene mutation in a dose-dependent manner. Doubling time of normally and slowly growing mutants was (14.6 +/- 1.74) h and (35.8 +/- 3.78) h respectively. The percentage of hemizygous LOH in CP-induced mutants (50%) was 2.4 times than that of the control (20.7%). CONCLUSIONS Great damage to TK gene is the main cause of mutation induced by CPin TK6 cells.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013937 Thymidine Kinase An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21. Deoxythymidine Kinase,Deoxypyrimidine Kinase,Kinase, Deoxypyrimidine,Kinase, Deoxythymidine,Kinase, Thymidine
D019656 Loss of Heterozygosity The loss of one allele at a specific locus, caused by a deletion mutation; or loss of a chromosome from a chromosome pair, resulting in abnormal HEMIZYGOSITY. It is detected when heterozygous markers for a locus appear monomorphic because one of the ALLELES was deleted. Allelic Loss,Heterozygosity, Loss of,Allelic Losses,Heterozygosity Loss

Related Publications

Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
July 2006, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
October 1993, Mutation research,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
April 2000, Toxicological sciences : an official journal of the Society of Toxicology,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
January 1989, Environmental and molecular mutagenesis,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
June 2004, Mutation research,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
May 2002, Radiation research,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
September 2004, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
March 1994, Radiation research,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
July 2006, Wei sheng yan jiu = Journal of hygiene research,
Li Zhan, and Li-shi Zhang, and Li Wang, and Hao Zhang, and Suzuki Takayoshi, and Honma Masamitsu, and De-sheng Wu
January 2011, Journal of toxicology and environmental health. Part A,
Copied contents to your clipboard!